In this study, we observed for the first time that the expression level of PHLDA2 was up-regulated, consistent with the majority of cancers, including liver cancer, colorectal cancer, glioma, lung cancer [17–19, 33]. The gene discussed is PHLDA2; the disease is central nervous system cancer.